In most cancer entities (e.g., pancreatic cancer, breast cancer, prostate cancer, lung cancer), EZH2 is clearly associated with pro-tumorigenic and tumor-progressive characteristics [33,34,35,36,37,38,39]. Here, EZH2 is linked to cancer.